Master css

Safety and Efficacy of Extreme Blood Pressure Lowering in Intracerebral Hemorrhage

Lunes, Marzo 1, 2021

Safety and Efficacy of Extreme Blood Pressure Lowering in Intracerebral Hemorrhage
Higher rates of neurologic deterioration and adverse events were associated with intensive treatment in patients with excessively high initial systolic blood pressure. Many patients with intracerebral hemorrhage (ICH) present with elevated systolic blood pressure (SBP). At times, SBP can be markedly elevated (>220 mm Hg).

PP-CNS-GLB-1605

©COPYRIGHT, DERECHOS RESERVADOS – PROHIBIDA SU REPRODUCCIÓN TOTAL O PARCIAL SIN AUTORIZACIÓN DE SU TITULAR. LAS MARCAS UTILIZADAS EN EL PRESENTE DOCUMENTO SON MARCAS REGISTRADAS A FAVOR DE SU TITULAR.
La información del producto provista está dirigida exclusivamente a cuerpo médico y/u odontológico que residan en Colombia. Pfizer Colombia 2014 - 2020.
Información adicional disponible en la Dirección Médica de Pfizer.

PP-PFE-COL-0966

For healthcare professionals only

If you are not a healthcare professional please visit [insert local link]

Master css

Safety and Efficacy of Extreme Blood Pressure Lowering in Intracerebral Hemorrhage

{* message_signIn *}

{* message_welcomeBack *}

{* message_welcomeBack *}

{* message_registeringThankYou *}

{* message_emailPasswordResetInstructions *}

Master css

You are here

Safety and Efficacy of Extreme Blood Pressure Lowering in Intracerebral Hemorrhage

Available on this website

For healthcare professionals only

{* message_withExistingAccount *}

{* message_joinNow *}

{* message_signIn *}

{* message_welcomeBack *}

{* message_welcomeBack *}

{* message_registeringThankYou *}

{* message_emailPasswordResetInstructions *}